Home  »  Industry   »  Trevena Inc. (TRVN) – Don’t Be So Quic...

Trevena Inc. (TRVN) – Don’t Be So Quick to Call it Dead

86 institutions hold shares in Trevena Inc. (TRVN), with 2.38M shares held by insiders accounting for 1.47% while institutional investors hold 14.46% of the company’s shares. Institutions hold 14.24% of the Float.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 7.08 million shares valued at $15.15 million. The investor’s holdings represent 4.39% of the TRVN Shares outstanding. As of Dec 30, 2020, the second largest holder is NEA Management Company, LLC with 3.81 million shares valued at $8.16 million to account for 2.36% of the shares outstanding. The other top investors are Blackrock Inc. which holds 2.63 million shares representing 1.63% and valued at over $5.63 million, while Geode Capital Management, LLC holds 0.70% of the shares totaling 1.14 million with a market value of $2.43 million.

Trevena Inc. (NASDAQ: TRVN) is -12.15% lower on its value in year-to-date trading and has touched a low of $0.46 and a high of $3.68 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TRVN stock was last observed hovering at around $1.86 in the last trading session, with the day’s gains setting it 0.02% off its average median price target of $5.00 for the next 12 months. It is also 68.67% off the consensus price target high of $6.00 offered by 5 analysts, but current levels are 62.4% higher than the price target low of $5.00 for the same period.

Currently trading at $1.88, the stock is -4.25% and -14.72% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.12 million and changing 1.08% at the moment leaves the stock -16.54% off its SMA200. TRVN registered 273.76% gain for a year compared to 6-month loss of -36.49%. The firm has a 50-day simple moving average (SMA 50) of $2.0717 and a 200-day simple moving average (SMA200) of $2.4080.

The stock witnessed a -9.62% gain in the last 1 month and extending the period to 3 months gives it a -12.15%, and is 2.73% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.57% over the week and 7.55% over the month.

Trevena Inc. (TRVN) has around 25 employees, a market worth around $291.81M and $3.10M in sales. Distance from 52-week low is 308.70% and -48.91% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.60%).

Trevena Inc. (TRVN) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Trevena Inc. (TRVN) is a “Buy”. 5 analysts offering their recommendations for the stock have an average rating of 2.00, where 1 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Trevena Inc. is expected to release its quarterly report on 08/05/2021 and quarterly earnings per share for the current quarter are estimated at -$0.08 with sales reaching $930k over the same period.The EPS is expected to grow by 15.20% this year, but quarterly earnings will post 266.90% year-over-year.

Trevena Inc. (TRVN) Insider Activity

A total of 10 insider transactions have happened at Trevena Inc. (TRVN) in the last six months, with sales accounting for 5 and purchases happening 5 times.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Trevena Inc. (TRVN): Who are the competitors?

The company’s main competitors (and peers) include Arena Pharmaceuticals Inc. (ARNA) that is trading 55.83% up over the past 12 months and Flexion Therapeutics Inc. (FLXN) that is 28.76% higher over the same period. AcelRx Pharmaceuticals Inc. (ACRX) is 47.22% up on the 1-year trading charts. Short interest in the company’s stock has risen 9.3% from the last report on Feb 11, 2021 to stand at a total of 18.83 million short shares sold with a short interest ratio of 5.6.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts




Download Free eBook For

100% free. stop anytime no spam


Download free eBook for